Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial

BACKGROUND: Due to prophylactic colectomy, mortality in patients with familial adenomatous polyposis (FAP) has changed, with duodenal cancer currently being the main cause of death. Although celecoxib reduces duodenal polyp density in patients with FAP, its long-term use may increase the risk of car...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: van Heumen, Bjorn WH, Roelofs, Hennie MJ, Vink-Börger, M Elisa, Dekker, Evelien, Mathus-Vliegen, Elisabeth MH, Dees, Jan, Koornstra, Jan J, Langers, Alexandra MJ, Nagtegaal, Iris D, Kampman, Ellen, Peters, Wilbert HM, Nagengast,, Fokko M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3750541/
https://ncbi.nlm.nih.gov/pubmed/23919274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-118
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak